These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers. Johnson KW; Neale A; Gordon A; Roessig J; Bezwada P; Vukelich S; Goldfine I; Rubin P J Clin Endocrinol Metab; 2017 Aug; 102(8):3021-3028. PubMed ID: 28605468 [TBL] [Abstract][Full Text] [Related]
11. XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesity. Bhaskar V; Lau A; Goldfine ID; Narasimha AJ; Gross LM; Wong S; Cheung B; White ML; Corbin JA Diabetes Obes Metab; 2013 Mar; 15(3):272-5. PubMed ID: 23039274 [TBL] [Abstract][Full Text] [Related]
12. Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells. Chan JY; LaPara K; Yee D Oncogene; 2016 Aug; 35(32):4235-43. PubMed ID: 26876199 [TBL] [Abstract][Full Text] [Related]
13. Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion. Verdecchia F; Akcan N; Dastamani A; Morgan K; Semple RK; Shah P Horm Res Paediatr; 2020; 93(6):396-401. PubMed ID: 33040071 [TBL] [Abstract][Full Text] [Related]
14. Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor. Srivastava A; Shankar K; Beg M; Rajan S; Gupta A; Varshney S; Kumar D; Gupta S; Mishra RK; Gaikwad AN J Mol Med (Berl); 2018 Apr; 96(3-4):315-331. PubMed ID: 29455245 [TBL] [Abstract][Full Text] [Related]
15. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds. Chan JY; Hackel BJ; Yee D Mol Cancer Ther; 2017 Jul; 16(7):1324-1334. PubMed ID: 28468775 [TBL] [Abstract][Full Text] [Related]
16. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Yamasaki H; Yamaguchi Y; Fujita N; Kato C; Kuwahara H; Yamauchi MD; Yamakawa K; Abe T; Ozaki M; Sera Y; Uotani S; Kawasaki E; Takino H; Eguchi K Acta Diabetol; 2000; 37(4):189-96. PubMed ID: 11450502 [TBL] [Abstract][Full Text] [Related]
17. Recurrent hypoglycemia during pregnancies in a woman with multiple autoantibodies including anti-insulin receptor antibody and anti-platelet antibody, whose serum lowered murine blood glucose levels and phosphorylated insulin receptor of CHO-IR cells. Toshihiro M; Katagiri H; Kataoka K; Fukushima A; Segawa T; Fujiwara T; Hikichi I; Takebe N; Satoh J Endocr J; 2011; 58(12):1037-43. PubMed ID: 21931226 [TBL] [Abstract][Full Text] [Related]
18. Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene. Dominici FP; Balbis A; Bartke A; Turyn D J Endocrinol; 1998 Oct; 159(1):15-25. PubMed ID: 9795337 [TBL] [Abstract][Full Text] [Related]
19. Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation. Innaurato S; Brierley GV; Grasso V; Massimi A; Gaudino R; Sileno S; Bernardini S; Semple R; Barbetti F Pediatr Diabetes; 2018 Jun; 19(4):670-674. PubMed ID: 29411486 [TBL] [Abstract][Full Text] [Related]
20. A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies With Fasting Insulin in Type B Insulin Resistance. Minich WB; Abel BS; Schwiebert C; Welsink T; Seemann P; Brown RJ; Schomburg L J Clin Endocrinol Metab; 2023 Aug; 108(9):2324-2329. PubMed ID: 36869714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]